RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced that Mary Blenn has been appointed to the newly created role of Executive Vice President and Chief Operating Officer, effective immediately. Ms. Blenn will report to President and CEO [...]

Acquisition deepens Revvity Signals’ presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY), today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end [...]

WALTHAM, Mass. -- Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical Device Innovation Consortium (MDIC) and the National Institute of Standards and Technology (NIST) as part of the Somatic Reference Samples (SRS) Initiative. The Somatic Reference Samples (SRS) Initiative is a public-private partnership convened and [...]

TeraView is pleased to announce a newly granted US patent that covers a pioneering test system designed for devices with multiple electrical contacts, integrating a movable probe assembly and a sophisticated profile-determining system. This system ensures precise mapping and reliable testing of advanced 2.5/3D packaging used in chips for artificial intelligence (AI), machine learning as well [...]

 A. ProteoScape™ (PS) software integrates the Kuiper machine learning-enhanced search engine, for immunopeptides, and TagGraph for neoepitope discovery. B. OmniScape™ + timsOmni™: next-generation de novo and glycoproteomics workflows with residue-aware scoring and intuitive visualization to accelerate intact proteoform and PTM analysis. C. Bruker and IPT announce a joint initiative to combine SampleStream™ with timsOmni™ for [...]

FOSS announces the acquisition of North American spectrometer specialist Wasatch Photonics. Hillerød, Denmark – The Danish family-owned company continues its investments within photonics and optics, this time with one of the biggest acquisitions in the history of the family business, spending just under DKK 250 million for the full ownership of the company. Wasatch Photonics is [...]

License enables Dyadic Applied BioSolutions to expand genetic engineering capabilities Dublin, Ireland, and Jupiter FL, USA: ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions (‘Dyadic’), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for diverse commercial applications, today announced they have signed a non-exclusive agreement granting access to ERS’ foundational [...]

Hamburg Germany -- acCELLerate, a manufacturer of assay-ready frozen cells has established an agreement with ATCC a global biological resource and standards organization. Under the agreement, acCELLerate will produce custom cell banks from ATCC cell lines for research clients in the pharmaceutical and biotechnology industry. This collaboration combines ATCC’s internationally recognized portfolio of high-quality, authenticated [...]

Following global commercial launch in September, Illumina Protein Prep's "out of the box" solution drives extraordinary accessibility to proteomics for researchers, with over 40,000 samples processed Sydney Mass Spectrometry is the first facility in the wider Asia Pacific region to offer Illumina Protein Prep, adding to a growing list of institutions revealing biological insights with exceptional [...]

Rockville, MD — OriGene Technologies, a global leader in gene-centric research tools, today announced an exclusive distributorship and a co-marketing partnership with Nanoportal Biotech for ProteanFect™, an industry-first, coacervate-based gene delivery reagent that promises to redefine transfection in challenging cell types. ProteanFect represents a major leap forward in nucleic acid delivery. Unlike conventional lipid- or polymer-based [...]